Wave life sciences announces upcoming presentations highlighting novel sirna program in obesity and leadership in rna editing

Presentation at the obesity & weight loss drug development summit to review real world evidence for the glp-1 class and the opportunity for wave's inhbe program as a best-in-class approach for obesity designed to induce fat burning and preserve muscle mass with once or twice-annual subcutaneous administration
WVE Ratings Summary
WVE Quant Ranking